Buy Annovis Bio Stock | ANVS Stock Price & Latest News | Public.com

ANVS

Annovis Bio

$0.00 (0.00%)Today

About ANVS

Annovis Bio, Inc. develops drugs for Alzheimer's and Parkinson's diseases and other neurodegenerative disorders. It offers posiphen compound for mild cognitive impairment and early stage Alzheimer's disease and bisnorcymserine compound that inhibits amyloid formation an...Read more

Community

People who own or watch this stock

Buy any stock with any amount of money.

Download the App
Download the app

What Wall Street Thinks

Rating

What Wall St. analysts suggest for this stock

1

Price Targets

What analysts think this stock will be worth

$5.99
current
$16.00
average

Earnings

The value each share was expected to gain vs. the value that each share actually gained

0
-0.05
-0.1
-0.15
Q1 2020
Q2 2020
Q3 2020

Expected EPS
Q3 2020

-$0.15

Actual EPS
Q3 2020

Stats

Market Cap$41,43M
Volume11,16k
Price-to-Earnings Ratio
Dividend Rate
Dividend Yield
1 Year High$10.61
1 Year Low$2.42
Open$5.55
High$6.08
Low$5.39

Buy any stock with any amount of money.

Download the App
Download the app